Fred Telling

Fred Telling, listed as board member, appears in our data through filings on Oragenics Inc shares, published by SEC (Form 4). In total, 11 filings cover trades dated from 29 June 2021 to 12 December 2025.

Both buying and selling appear: 5 purchases worth €66k, against 4 sales worth €13k. Taken together, the purchases exceed the sales by €53k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 share grant and 1 option exercise. 2026 to date brings no purchases and 1 sale.

Half of the purchases are above €3,814 and half below. 1 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The record was last updated on 22 January 2026 with an open-market sale (€169) in Oragenics Inc. The latest purchase dates back some time: it was published 1,580 days ago, on 21 June 2022. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.